Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Unless specifically stated otherwise, these products are not approved by the U.S
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)
Evaluated transdermal delivery of copper tripeptide, demonstrating penetration through skin layers with potential for topical therapeutic applications
End-to-End Support We support your research at every step
Not approved for human or animal administration, therapeutic, or diagnostic applications
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
